
You're going to be okay.
When you test positive for an inherited BRCA1 or BRCA2 mutation, you're given results, but not a plan. We turn your information into guidance you can trust.
Your Care, Simplified
MOTA is a digital companion designed to help women with BRCA1 or BRCA2 mutations move from “I have this result… now what?” to clear, actionable next steps.
Step 1
Get Your Personalized Roadmap
Answer a few questions about your BRCA result and health history. We'll create an evidence-based action plan tailored to your unique situation, including screening schedules, risk-reduction options, and family planning considerations.
Step 2
Find Vetted Specialists
Search our curated directory of clinicians who specialize in hereditary cancer care, including genetic counselors, gynecologic oncologists, and breast surgeons. Filter by location and expertise to find the right fit for you.
Step 3
Plan & Track Your Care
Use our timeline tool to organize appointments, track screenings, and set reminders. Everything you need to stay on top of your care, all in one place.
Step 4
Find Others Like You
Read real stories from women navigating similar journeys.
Your BRCA Care Plan
MOTA helps turn BRCA 1 and 2 guidelines into a personalized roadmap for screening, surgery decisions, and next steps.



Featured Stories
Real journeys, in their own words

“IVF gave us something BRCA doesn't always give you: a choice about what we pass on.”


“I just wanted someone to hand me a blueprint and say: start here—and do this for the rest of your life.”
Meet Our Advisors
Expert leadership from healthcare professionals who understand the BRCA+ journey

Krista Brown, MS, RN, ONN, CFNC
Oncology Nurse NavigatorKrista is an oncology nurse navigator and passionate advocate for the hereditary cancer community. As both a healthcare professional and breast cancer survivor living with a genetic ATM mutation, Krista brings lived experience to her work. With a masters degree in medical nutrition and 14 years of nursing experience, she guides patients through diagnosis, treatment, survivorship, and preventative care. She truly believes knowledge is power, and her mission is to educate and empower individuals at increased risk so they can take proactive steps to protect their health and future.

Rachel Frankenthal, PA-C, MPH, MSCP
Gynecologic OncologyRachel Frankenthal is a board-certified and licensed Physician Associate and Certified Menopause Practitioner with a Masters in Public Health. She specializes in gynecologic oncology, treating women with gynecologic cancers as well as women at high risk for cancer due to genetic mutations or a strong family history. A vocal advocate for menopause-informed care, Rachel focuses on patient-centered decision-making that balances medical evidence, symptom management, and quality of life. She runs a menopause clinic for cancer survivors and previvors and teaches a course on hormone therapy for gynecologic cancer survivors through the Heather Hirsch Academy.

Daniella Kamara, MS, LCGC
Cancer GeneticsDaniella Kamara is a cancer genetic counselor at University of California, Los Angeles (UCLA). She has been a cancer genetic counselor for over 10 years and works both in the clinical and research settings helping individuals and families who face a hereditary predisposition to cancer. She has contributed to various research studies over the years aiming to increase access to hereditary cancer testing, creating novel models for support for individuals and their family members, and exploring population-based testing models. She is passionate about supporting patients and their family members to feel empowered by their genetic test results and finding ways to make it easier to navigate healthcare for those facing a hereditary predisposition to cancer.

Marleah Dean Kruzel, PhD
Hereditary Cancer CommunicationDr. Marleah Dean Kruzel's research and speaking focus on communication in healthcare, with particular emphasis on hereditary cancer. A BRCA2 previvor, she studies how patients, families, and clinicians exchange information, manage uncertainty, and make informed decisions across the cancer prevention and care continuum. She is also a Scientific Advisory Board Member for the non-profits Facing Our Risk of Cancer Empowered (FORCE) and My Faulty Gene.
From the Founder

“I received my BRCA2+ result in a way that felt abrupt and clinical. I shut down.”
With the right context, this information is empowering. It gives you options. It gives you agency.
MOTA is designed to provide that structure and clarity from the start.
Our mission is to empower every woman with a BRCA mutation to make informed decisions about her health with confidence, supported by expert guidance and a caring community.
— Randi Eichenbaum
Frequently Asked Questions
Everything you need to know about MOTA
Still have questions? Contact our team
Stay Informed
Not ready to dive in yet? Join our mailing list for updates, research insights, and helpful resources. Get periodic updates about hereditary cancer care, BRCA research, and community stories. We'll also let you know when new features launch.
You're subscribed!
Thank you for subscribing. We'll keep you updated with the latest news and resources.